Latest news
Insulet (PODD) Is Down 15.9% After Cutting 2026 Revenue Guidance on Type 2 Retention Strains - webull.comwebull.com · Mon, 10 Aug 2026 08:52:03 GMTInsulet Earnings Call: Growth Intact Amid Type 2 Reset - TipRanksTipRanks · Thu, 06 Aug 2026 01:25:11 GMTInsulet Corp (PODD) (Q2 2026) Earnings Call Highlights: Strong R - GuruFocusGuruFocus · Wed, 05 Aug 2026 19:01:11 GMTThis Medtech Beat Earnings, but the Stock Is Having Its Worst Day in 17 Years - Barron'sBarron's · Wed, 05 Aug 2026 18:43:00 GMTInsulet Beats Q2 on Every Metric, Cuts Guidance: Type 2 Patients Quit Before 90 Days - Tech TimesTech Times · Wed, 05 Aug 2026 17:42:19 GMTLost Money on Insulet Corporation (PODD)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky - PR NewswirePR Newswire · Wed, 05 Aug 2026 14:09:00 GMTInsulet Raises 2026 Adj EPS Growth to Over 30% >PODD - MoomooMoomoo · Wed, 05 Aug 2026 11:10:00 GMTInsulet Reports Second Quarter 2026 Results - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 11:00:00 GMT